Literature DB >> 16933260

Gene expression profile of idiopathic thrombocytopenic purpura (ITP).

Ruchira Sood1, Wendy Wong, Michael Jeng, James L Zehnder.   

Abstract

To search for novel mechanisms that contribute to the pathophysiology of idiopathic thrombocytopenic purpura (ITP), we determined the whole blood gene expression profile in five ITP patients and five control samples. Using DNA microarrays that contained 24,473 unique putative genes, we found 176 cDNAs that were strongly correlated with ITP. These included a cluster of interferon-regulated genes and TLR7, as well many less-well characterized genes which are candidates for further study. We believe this approach is likely to yield new insights into our understanding of the molecular pathophysiology of ITP. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16933260     DOI: 10.1002/pbc.20981

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach.

Authors:  Maria L Lozano; Cristina Segú-Vergés; Mireia Coma; María T Álvarez-Roman; José R González-Porras; Laura Gutiérrez; David Valcárcel; Nora Butta
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

2.  Pathway of Toll-like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo.

Authors:  Qing Yang; Shuqian Xu; Xiaofang Li; Bo Wang; Xuping Wang; Daoxin Ma; Lei Yang; Jun Peng; Ming Hou
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

Review 3.  Long Noncoding RNA HCP5, a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations.

Authors:  Jerzy K Kulski
Journal:  Cells       Date:  2019-05-20       Impact factor: 6.600

4.  Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia.

Authors:  Shuo Zhang; Jingge Qu; Li Wang; Mengtao Li; Dong Xu; Yan Zhao; Fengchun Zhang; Xiaofeng Zeng
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.